Literature DB >> 938167

Inhibition of platelet aggregation by alpha1-acid glycoprotein.

S Snyder, E L Coodley.   

Abstract

In view of known abnormalities of plasma proteins in diseases showing changes in platelet aggregation, the effect of one of the major serum proteins, alpha1-acid glycoprotein, on platelet aggregation was evaluated. This protein, when added to platelet-rich plasma, markedly inhibited platelet aggregation induced by both adenosine diphosphate (ADP) and epinephrine. Transferrin, similarly studied, had no effect. These results are consistent with the hypothesis that the relative concentration of alpha1-acid glycoprotein may influence platelet aggregation in diseases associated with abnormal concentrations of this protein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938167

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Influence of menstrual cycle phase on serum concentrations of alpha 1-acid glycoprotein.

Authors:  R C Parish; C Spivey
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Structure of the rat alpha 1-acid glycoprotein gene.

Authors:  Y C Liao; J M Taylor; J L Vannice; G A Clawson; E A Smuckler
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

3.  Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs.

Authors:  Masashi Yuki; Noboru Machida; Takayuki Sawano; Hiroshi Itoh
Journal:  Vet Res Commun       Date:  2010-10-21       Impact factor: 2.459

4.  [Thrombocyte function in essential thrombocythemia and reactive thrombocytosis].

Authors:  B Baumann; I Hillmar; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01

5.  Control of malaria virulence by alpha 1-acid glycoprotein (orosomucoid), an acute-phase (inflammatory) reactant.

Authors:  M J Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties.

Authors:  Giovanni Ligresti; Alfred C Aplin; Bruce E Dunn; Ann Morishita; Roberto F Nicosia
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 7.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.